Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Effects of Exercise on Functional Ability in People With Dementia in Nursing Homes:a Cluster Randomised Controlled Trial [NA]
This update reports the results of a cluster randomized controlled trial evaluating the impact of a structured exercise program on functiona…
-
CLINICAL_TRIALS other · 2025-12-10Clinical Trial Update: Neuclare Device for Temporary Improvement of Executive Function in Patients With Mild Cognitive Impairment and Prodromal Alzheimer's Disease [NA]
Clinical trial update on the Neuclare Device to temporarily improve executive function in individuals with mild cognitive impairment and pro…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD) [Phase 2]
This is a Phase 2 clinical trial update for transcranial photobiomodulation being investigated in Alzheimer's disease and mild cognitive imp…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Evaluation of a Finger Prick Collection Method for Measuring Alzheimer's Disease Blood Biomarkers
This completed clinical trial evaluated a finger-prick blood collection method for measuring biomarkers associated with Alzheimer's disease.
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR) [NA]
Cilcare SAS's SAPHIR trial (NCT07083089) is actively recruiting to study hearing relevance in early-stage Alzheimer's and Parkinson's diseas…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Draw-10: A Weekly Blood Draw Study to Understand the Biological Variability of Plasma pTau-217
Draw-10, a weekly blood draw study investigating the biological variability of plasma pTau-217 in Alzheimer's disease, has completed.
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: GeneMatch: A Program of the Alzheimer's Prevention Registry to Match Individuals to Studies Based on Apolipoprotein E (APOE) Genotype
GeneMatch is a program from the Alzheimer's Prevention Registry (sponsored by Banner Health) that matches individuals to Alzheimer's disease…
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation [Phase 3]
Phase 3 trial assessing long-term safety and efficacy of AXS-05 in Alzheimer's disease agitation has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: Relationship Between Alzheimer Disease and Diminution of the Three Macular Nervous Retinal Layers [NA]
A completed clinical trial study examining the relationship between Alzheimer's disease and diminution of three macular retinal layers measu…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
This UC Davis–led clinical trial update describes enrolling by invitation a study using optical coherence tomography to determine if retina …
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Evaluation of the Effectiveness of Virtual Reality Headsets With Hypnotic Scenarios for Hygiene Care in Patients With Alzheimer's Disease or Related Disorders With Behavioral Disturbances [NA]
A clinical trial is evaluating the effectiveness of virtual reality headsets with hypnotic scenarios to aid hygiene care in patients with Al…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition [NA]
A Pennington Biomedical Research Center-sponsored clinical trial is evaluating whether physiologic insulin administration improves insulin s…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's Disease [Phase 2]
A Phase 2a trial evaluating REM0046127 in mild to moderate Alzheimer's disease has been terminated.
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A) [Phase 3]
A Phase 3 clinical trial evaluating the NirsCure-03A near-infrared light therapy device for Alzheimer's disease is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Music, Social Attention, and Dementia [NA]
A UCSF-sponsored clinical trial update for a study on music, social attention, and dementia, including Frontotemporal dementia and Alzheimer…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: An Investigation Into the Feasibility of Beetroot Juice Supplementation in People Living With Alzheimer's Disease. [NA]
A feasibility study investigating beetroot juice supplementation in people living with Alzheimer's disease; the trial is currently not recru…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Predictors of Emergency Department Use in Frail Patients
University of Pisa is recruiting for a study to identify predictors of emergency department visits among frail elderly patients, including t…
-
CLINICAL_TRIALS trial_result · 2025-12-02Clinical Trial Update: Locus-coeruleus Function in Normal Elderly and AD Risk [NA]
A completed study evaluating locus coeruleus function in cognitively normal older adults and its relation to Alzheimer's disease risk.
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: N-DOSE AD: A Dose Optimization Trial of Nicotinamide Riboside in Alzheimer's Disease [Phase 2]
Phase 2 dose-optimization trial of nicotinamide riboside for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: Improving Sleep and Cognition in Alzheimer's Disease [NA]
A completed clinical trial from Emory University evaluating sleep and cognition in Alzheimer's disease.
-
EMA approval · 2025-11-28EMA Authorised: Memantine Mylan (memantine hydrochloride) — Mylan Pharmaceuticals Limited
EMA authorised Memantine Mylan (memantine hydrochloride) for Alzheimer's disease. The marketing authorization holder is Mylan Pharmaceutical…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: A Study of Retinal Imaging to Detect Abnormal Protein Deposits Associated With Alzheimer's Disease
Eli Lilly is sponsoring a clinical trial evaluating retinal imaging to detect abnormal protein deposits linked to Alzheimer's disease, which…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Frailty Outcomes And Risk With Alzheimer's Related Dementia
An ongoing clinical trial sponsored by Aalborg University Hospital is studying frailty outcomes and risk in patients with Alzheimer's diseas…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation [Phase 3]
Phase 3 study evaluating AXS-05 for agitation in Alzheimer's disease has completed.
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Understanding the Lived Experience and Bereavement of Caregivers of People With Alzheimer's Disease
This clinical trial update describes a Universidad Rey Juan Carlos study exploring the lived experience and bereavement of caregivers of peo…